its yeast homologue were shown to protect the translocon by cleaving obtruding proteins, thereby maintaining homeostasis of the endoplasmic reticulum (Ast et al., 2016) . ZMP STE24 has promiscuous substrate specificity cleaving a heterogeneous spectrum of prenylated and nonprenylated targets (Ast et al., 2016; Hildebrandt et al., 2016) .
Many enveloped viruses are ferried deep into the cytoplasm through endocytic vesicles and use the low pH endosomal environment to activate viral fusion proteins (Cossart and Helenius, 2014) . Higher vertebrates evolved interferon-induced transmembrane protein (IFI TM) family proteins to hinder endosomal penetration by fusogenic viruses (Brass et al., 2009; Perreira et al., 2013; Bailey et al., 2014) . We now report the antiviral properties of IFI TM are dependent on ZMP STE24. results and dIscussIon ZMP ste24 restricts viral infection, independent of its protease activity HEK293 cells stably expressing C-terminal FLAG-tagged IFI TM3 were stimulated with interferon. Affinity purification coupled with mass spectrometry (AP-MS) identified IFI TM3-associated proteins. The significance analysis of interactome (SAI NT) algorithm was adopted to analyze AP-MS data in combination with our reference database of FLAG-tagged protein complexes purified under identical conditions (Fu et al., 2015) . 10 high-confidence interacting proteins including ZMP STE24 with SAI NT scores >0.89 were identified (Table S1 ).
Zinc metallopeptidase ste24 (ZMP ste24) is a transmembrane metalloprotease whose catalytic activity is critical for processing lamin a on the inner nuclear membrane and clearing clogged translocons on the endoplasmic reticulum. We now report ZMP ste24 is a virus-specific effector that restricts enveloped rna and dna viruses, including influenza a, Zika, ebola, sindbis, vesicular stomatitis, cowpox, and vaccinia, but not murine leukemia or adenovirus. ZMP ste24-mediated antiviral action is independent of protease activity. coimmunoprecipitation studies indicate ZMP ste24 can complex with proteins of the interferoninduced transmembrane protein (IFI tM) family. IFI tM proteins impede viral entry, and ZMP ste24 expression is necessary for IFI tM antiviral activity. In vivo studies demonstrate ZMP ste24-deficient mice display higher viral burdens, enhanced cytokine production, and increased mortality after influenza infection. collectively, these findings identify ZMP ste24 as an intrinsic broad-spectrum antiviral protein and provide insights into antiviral defense mechanisms.
Coimmunoprecipitation studies examined interactions between ZMP STE24 and IFI TM family proteins. ZMP STE24 specifically binds IFI TM1, IFI TM2, or IFI TM3 ( Fig. 1 A) . In contrast to IFI TM, ZMP STE24 transcription is not up-regulated by IFNβ stimulation (Fig. 1 B) . To investigate the antiviral function of ZMP STE24, HEK293 cells were transiently transfected with FLAG-tagged or control untagged ZMP STE24 24 h before infection with influenza A/Puerto Rico/8/1934 virus (PR8) with Gaussia luciferase (GLuc; PR8-GLuc) reporter virus (Heaton et al., 2013) . Both constructs inhibited influenza A virus (IAV) reporter activity ( Fig. 1 C) . Next, A549 lung cells were transfected with ZMP STE24-FLAG; after 2 d, the cells were infected with PR8 IAV and examined by immunofluorescence. Ectopic expression of ZMP STE24 limits and delays viral infection ( Fig. 1 D) . Furthermore, A549 cells expressing ZMP STE24 produce fewer infectious IAV particles, as measured by plaque assay (Fig. 1 E) .
To investigate viral specificity, ZMP STE24 transfected cells were infected with vesicular stomatitis virus (VSV) carrying a firefly luciferase (Luc) gene (VSV-Luc; Cureton et al., 2012) . ZMP STE24 strongly inhibited VSV reporter activity ( Fig. 1 F) . Thus, the effect of ZMP STE24 overexpression was tested on additional RNA viruses (Sindbis, murine leukemia virus [MLV], and Zika). ZMP STE24 also inhibited Sindbis reporter activity, but not MLV ( Fig. 1 F) . Ectopic ZMP STE24 expression also inhibits Zika infection in human T98-G glioblastoma cells (Fig. 1 G) . Next, we examined the ability of ZMP STE24 to restrict infection with three DNA viruses: adenovirus (AdV), vaccinia virus (VACV), and cowpox virus. Overexpression of ZMP STE24 inhibited infection with VACV and cowpox virus, but not AdV ( Fig. 1 F) . As the IFI TM sensitivity of pox viruses was not previously reported, we compared the ability of these viruses to infect ifitmDel −/− (deletion of ifitm1, 2, 3, 5, and 6) and reconstituted cells. The data indicate IFI TM selectively protects against pox virus infection ( Fig. 1 H) .
To corroborate the role of ZMP STE24 in antiviral defense, zmpste24 −/− MEFs were examined. Plaque assays establish increased IAV production by zmpste24 −/− cells ( Fig. 2 A) . To evaluate antiviral specificity, zmpste24 −/− and zmpste24 +/+ MEFs were infected with VSV, Sindbis, MLV, VACV, cowpox, and AdV. Deficiency of ZMP STE24 enhanced VSV, Sindbis, cowpox, and VACV reporter activity, but not MLV and AdV (Fig. 2 B) . Importantly, reconstitution of zmpste24 −/− MEFs with human ZMS PTE24 restored antiviral activity (Fig. 2 C) . ZMP STE24 knockdown also enhanced Zika virus replication in T98-G glioblastoma cells (Fig. 2 D) . Finally, we examined the effects of ZMP STE24 deficiency on primary human tracheal cells. RNAi depletion of ZMP STE24 increased IAV, VSV, Sindbis, cowpox, and VACV infection in primary human respiratory epithelial cells (Fig. 2 E) . To exclude RNAi off-target effects, cells were transfected with an siRNA-resistant ZMP STE24 rescue construct before infection with PR8 reporter virus. The rescue construct restored antiviral activity, validating siRNA specificity ( Fig. 2 F) . The combined data suggest ZMP STE24 restricts infection by selected RNA and DNA viruses.
To ascertain if enzymatic activity is critical for viral restriction, we mutated residues within the conserved HEX XH zinc metalloprotease motif, which is essential for catalytic activity (Pryor et al., 2013; Quigley et al., 2013) . Wild type and mutants H335A and E336A exhibited comparable protection against IAV infection in A549 cells ( Fig. 3 A) . In addition, various ZMP STE24 mutations identified from patients with reduced enzymatic activity also displayed antiviral activity, with the exception of the L94P mutation, which lacked protein expression ( Fig. 3 A) . Furthermore, zmpste24 −/− MEFs reconstituted with human ZMP STE24 or the E336A catalytically inactive mutant restored host restriction to IAV, VSV, and VACV ( Fig. 3 B) . Collectively, the combined data suggest protease activity is not essential for ZMP STE24 antiviral function.
ZMP ste24 cooperates with IFI tM to inhibit viral entry
Most enveloped viruses enter cells by breaching endosomal membrane barriers. To investigate the role of ZMP STE24 in viral entry, we examined the effects of ZMP STE24 overexpression on IAV release from endosomes. ZMP STE24 restrained IAV release from highly acidic LysoTracker red-positive vesicles in A549 cells ( Fig. 3 C) . Furthermore, direct viral fusion assays using virus-like particles (VLPs) demonstrate zmpste24 −/− cells are more susceptible to IAV viral entry than zmpste24 +/+ cells ( Fig. 3 D) . In contrast, ZMP STE24 expression has no effect on entry of MLV particles ( Fig. 3 D) . Zmpste24 −/− cells also demonstrated increased susceptibility to infection with VLP containing glycoproteins from HA1, HA5, or HA7 IAV, VSV, and Ebola ( Fig. 3 E) . Reciprocally, ZMP STE24 overexpression inhibited entry of IAV, VSV, and Ebola VLP ( Fig. 3 F) . Collectively, the data suggest ZMP STE24 impedes viral endosomal entry.
To establish the functional relationship between ZMP STE24 and IFI TM3, we performed genetic complementation experiments. Ectopic expression of IFI TM3 does not restore antiviral function in zmpste24 −/− cells ( Fig. 3 B) . However, ectopically expressed ZMP STE24 restores antiviral activity against IAV, VSV, and VACV in ifitmDel −/− cells ( Fig. 3 G) .
To determine whether ZMP STE24 can still exert antiviral activity in the absence of IFI TM, we silenced ZMP STE24 in ifitmDel −/− MEFs. Notably, ZMP STE24 knockdown uncovers an IFI TM-independent restriction on VSV and VACV infection ( Fig. 3 H) . The combined results imply ZMP STE24 is required for IFI TM antiviral action, although the need for IFI TM can be bypassed. The data are compatible with a model in which ZMP STE24 serves as a downstream effector in the IFI TM pathway, although an IFI TM-independent pathway also exists. Figure 1 . ZMP ste24 protects against viral infection. (A) ZMP STE24-FLAG was transfected with HA-tagged STI NG, IFI TM1, IFI TM2, or IFI TM3 into HEK293 cells. After 48 h, cells were lysed and immunoprecipitated with anti-HA antibody and blotted with the indicated antibodies. Data are representative of two independent experiments. Molecular mass is indicated in kilodaltons. IP, immunoprecipitation; WB, Western blot. (B) A549 cells were stimulated with 5 U IFNβ for the designated times. IFI TM1, IFI TM2, IFI TM3, ZMP STE24, and control GAP DH mRNA levels were examined by real-time PCR (three independent experiments). Mean ± SD; *, P < 0.05. (C) Empty vector, ZMP STE24-FLAG, or untagged ZMP STE24 were transfected into HEK293 cells. After 24 h, cells were
ZMP ste24 is required for influenza restriction in vivo
The progeria phenotype of zmpste24 −/− mice can be complemented by reducing the level of prelamin A. Zmpste24 −/− mice with half-normal levels of prelamin A are protected from disease (Fong et al., 2004 (Fong et al., , 2006 Varela et al., 2005; Mariño et al., 2008) and mount normal primary antibody responses after immunization with a limiting dose of IAVderived HA protein ( Fig. 4 A) . To define the in vivo role of ZMP STE24 on viral restriction, we compared antiviral responses of lmna +/− zmpste24 −/− , lmna +/− zmpste24 +/− , and lmna +/− zmpste24 +/+ animals. ZMP STE24-deficient mice displayed increased susceptibility to IAV with signs of severe clinical illness, including lethargy, hunched posture, and accelerated weight loss ( Fig. 4 B) . The weight loss in zmp-ste24 heterozygous mice was intermediate, suggesting a gene dose effect ( Fig. 4 B) . 65% of zmpste24 −/− animals became moribund (defined as 25% loss of body mass) compared with 20% and 0% in other groups (Fig. 4 C) . IAV was detected in the lungs of all infected animals but did not spread to the spleen ( Fig. 4 D) . Lungs from ZMP STE24-deficient mice exhibit the greatest increase in viral load. A gene dose effect was noted in the zmpste24 +/− group (Fig. 4 D) . Two days after infection, lungs from IAV-infected ZMP STE24deficient animals displayed focal areas of vasculitis and bronchitis with mixed polynuclear/mononuclear infiltrates and scattered areas of epithelial necrosis, whereas less pathology was noted in controls ( Fig. 4 E) . The histological findings were supported by increased levels of cytokines (IFNβ, TNF, and IL-6) and chemokines (MCP1/CCL2 and KC/ CXCL1) in the lungs of IAV-infected zmpste24 −/− animals ( Fig. 4 F) . After IAV infection, pulmonary IFI TM3 expression was enhanced in zmpste24 −/− and control mice. In contrast, ZMP STE24 mRNA remained at constitutive levels after IAV infection ( Fig. 4 G) . The findings indicate ZMP STE24 expression is not regulated by viral infection. The combined data suggest ZMP STE24 deficiency is associated with enhanced viral proliferation and correspondingly more extensive tissue damage and imply ZMP STE24-deficient mice are unable to control influenza infection.
In summary, ZMP STE24 is an intrinsic antiviral protein that protects against pathogen attack. Of nine tested viruses, ZMP STE24 selectively restricted infection by six distinct viridae families, representing diverse groups of enveloped RNA and DNA viruses. All ZMP STE24-sensitive viruses require access to acidic endosomal compartments for viral entry.
Representatives of each architectural class of fusogenic viral glycoprotein (Harrison, 2015) are susceptible to ZMP STE24 inhibition, suggesting a common mechanism that alters endosomal trafficking or membrane structure rather than direct interaction with this varied assortment of virally encoded fusion proteins. Although we cannot exclude the possibility that ZMP STE24 or IFI TM associate with a common host-derived membrane element present in the viral envelop.
The best-characterized host restriction proteins involved in regulating viral entry are members of the IFI TM family. ZMP STE24 is detected in IFI TM protein complexes and restricts a similar spectrum of RNA and DNA viruses. Genetic complementation experiments indicate ZMP STE24 is required for IFI TM antiviral activity, placing these two transmembrane proteins in a common pathway.
Viral endocytic entry is a complex process, involving endosomal trafficking, endosomal maturation, membrane bending, fluidity of membrane lipids, pre-hemifusion, and post-hemifusion events. Host proteins may interfere with different steps of the viral endocytic entry process. At the current stage, it is not clear which steps involve ZMP STE24, how ZMP STE24 antiviral activity is regulated, or whether other cofactors interact with ZMP STE24. Nonetheless, ZMP STE24 is an important element for innate host defense against a broad spectrum of pathogenic viruses.
MaterIals and Methods Mouse infection
Zmpste24 +/− and lmna +/− animals on a C57BL background (N3 and N9, respectively) were purchased from Mutant Mouse Resource and Research Centers and The Jackson Laboratory, respectively. Intercrossed mice were maintained under specific pathogen-free conditions before infection. To avoid the complications of progeria, all experimental mice were heterozygous for the lmna gene (Fong et al., 2004 (Fong et al., , 2006 Varela et al., 2005; Mariño et al., 2008) . Cohorts of age matched (2-4 mo) mice were anesthetized with 100 µg/g ketamine: 5 µg/g xylazine and then inoculated intranasally with 200 pfu influenza A/PR/8/34 in 20 µl sterile PBS. Weights were recorded daily as well as monitoring for signs of illness. Mice with 25% weight loss were considered moribund and euthanized. For histopathology, lungs from infected mice were fixed in Bouin solution (3 d) or 10% formalin (24 h) before transfer to 70% ethanol. Specimens were paraffin-embedded and stained by the Dana Farber/Harvard Cancer Center Histopathology infected with 0.1 MOI PR8-GLuc for 16 h. Cell viability was determined by CellTiter-Glo, which was used for normalization (three experiments). Mean ± SD; *, P < 0.05. (D) A549 cells transfected with ZMP STE24-FLAG (48 h) and then infected with 1 MOI PR8 for the indicated times (two experiments; percentage of positive cells from five fields ± SD are denoted). Bars, 100 µm. (E) A549 cells transfected with ZMP STE24-FLAG were infected with 0.001 MOI WSN IAV for 12 h. Virus titers were determined by plaque assay. Data are representative of three experiments. Mean ± SD; *, P < 0.05. (F) A549 cells transfected with ZMP STE24-FLAG were infected with 1 MOI IAV-GLuc, VSV-Luc, Sindbis-Luc, MLV-Luc, VACV-Luc, cowpox-Luc, and AdV5-Luc for 16 h (consolidated data). Each group was analyzed three times. Mean ± SD; *, P < 0.05. Viability assays of infected cells indicate <20% differences among groups. (G) GFP-FLAG or ZMP STE24-FLAG was transfected in T98-G cells for 24 h before infection with 0.01 MOI MR 766 Zika virus. After 72 h, Zika virus titers were determined by plaque assay (three experiments). Mean ± SD; *, P < 0.05. (H) Wild-type, ifitmDel −/− , and reconstituted MEFs were infected with 1 MOI AdV, VACV-Luc, or cowpox-Luc for 16 h. Relative luciferase activities were examined (three experiments). Mean ± SD; *, P < 0.05. core services. All experiments were performed with approval of Harvard Medical School, Committee on Animals.
Immunization
Animals were immunized s.c. in two sites with a total of 10 µg purified PR8-derived HA antigen (Sino Biologicals) precipitated with 2 mg magnesium hydroxide and 2 mg aluminum hydroxide.
antibodies Source, application, and dosage are indicated sequentially as follows: anti-β-actin (WB [1:1000]; Abcam), anti-FLAG (WB [1:1,000]; Sigma-Aldrich), anti-NP (IFA [1:1,000]; EMD Millipore), anti-HA epitope (WB [1:1,000]; Sigma-Aldrich), monoclonal anti-ZMP STE24 antibody (described elsewhere; Pendás et al., 2002; WB [1:500] ; gift from C. López-Otin, University of Oviedo, Oviedo, Spain), goat anti-rabbit IgG-HRP (WB [1:10,000]; Santa Cruz Biotechnology, Inc.), and Alexa Fluor 488 or 594 goat anti-mouse IgG (H+L, IFA [1:200]; Thermo Fisher Scientific).
Plasmids
Human ZMP STE24, IFI TM1, IFI TM2, and IFI TM3 cDNA were provided by the Dana Farber/Harvard Cancer Center DNA Resource Core. C-terminal epitope-tagged constructs were made by cloning into pCMV-3Tag-8 (Agilent Technologies). Mutations of ZMP STE24-FLAG were constructed using the QuikChange II Site-Directed Mutagenesis kit (Bergo et al., 2002;  a gift from S. Young, University of California, San Francisco, San Francisco, CA) were maintained in DMEM containing antibiotics and 10% FBS. A549 and T98-G cells (ATCC) were cultured in RPMI Medium 1640 plus 10% FBS and 1× MEM nonessential amino acids solution. Primary human tracheal epithelial cells and supporting medium were purchased from Lifeline Technology.
Viruses
Influenza PR8-GLuc virus with a GLuc gene inserted downstream of PB2 was a gift from P. Palese (Mount Sinai School of Medicine, New York, NY; Heaton et al., 2013) . IAV was propagated in specific pathogen-free fertilized eggs Premium Plus (Charles River) according to previously published protocols (Szretter et al., 2006) . IAV was titered by plaque assay as described elsewhere (Matrosovich et al., 2006) .
VSV-Luc was a gift from S. Whelan (Harvard Medical School, Boston, MA). VACV with Luc gene (VACV-Luc) was a gift from D.L. Bartlett (University of Pittsburg, Pittsburg, PA). Cowpox virus expressing luciferase was a gift from B. Moss (National Institutes of Health, Bethesda, MD). Sindbis virus carrying luciferase gene was a gift from R. Andino (University of California, San Francisco, San Francisco, CA) and J. Kagan (Children's Hospital, Boston, MA). VSV-Luc and VACV-Luc were expanded in BHK-21 cells. Adenovirus 5 with luciferase was purchased from the University of Iowa Viral Vector Core. Zika virus MR 766 was supplied by BEI Resources. For Zika plaque assays, Vero cells (ATCC) were grown to 90% confluence and then incubated with viral samples for 1 h at 37°C. Afterward, virus was removed and cells were washed with PBS. The cells were then covered with 2% methyl-cellulose in DMEM containing 2% FBS for 6 d and stained with crystal violet.
reporter assay For reporter virus assay, cells were counted using Countess Automated Cell Counter (Invitrogen), and equal numbers of cells were split into culture plates. 16 h later, cells were infected with indicated reporter virus for 16 h and then collected for reporter assay. Gaussia (New England BioLabs, Inc.) and Luc (dual-luciferase reporter assay; Promega) substrates were used as recommended by manufacturer. Each experiment was performed in triplicate. P-values were determined with paired Student's two-tailed t test. Cell number was assessed using the CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Pseudotyped virus
For viral infection activity assay, pseudotyped viruses were generated by coexpression of indicated viral envelope construct and MSCV IRES luciferase (Addgene; donated by S. Lowe, Cold Spring Harbor, NY) in HEK293 cells. MSCV IRES luciferase plasmid was cotransfected with pCL-Ampho Retrovirus Packaging Vector (IMG ENEX) into HEK293 cells to generate MLV-Luc pseudoviruses.
entry assay using VlPs
The entry assay was based on a previously published protocol (Tscherne and García-Sastre, 2011) with minor modifications as follows. To prepare IAV VLPs, HEK 293 cells were transfected with β-lactamase M1 (BlaM1; β-lactamase was fused to WSN/33 M1 gene, a gift from A. Garcia-Sastre, Mount Sinai School of Medicine, New York, NY) and WSN/33 NA plus WSN/33 HA, or VN/2004 H5N1-HA or Anhui/2013 H7N9-HA. To make VLPs for VSV, HEK293 cells were transfected with BlaM1 and VSV-G. For preparation of the Zaire Ebola virus VLPs, BlaM-VP40 and Ebola glycoprotein (gifts from L. Rong, University of Illinois, Chicago, IL) were transfected into HEK293 cells. Medium containing influenza VLPs was treated with 2 µg/ml TPCK-trypsin for 30 min at 37°C to cleave HA. For preparation of MLV particles, MLV envelop (pHCMV-EcoEnv; Addgene) was cotransfected with BlaM-VP40 in HEK293 cells.
zmpste24 −/− cells were infected with IAV (HA1, HA5, and HA7), VSV, and Ebola VLP (2 h) and then assayed for viral entry with CCF2. Data are representative of two or more experiments per group. Mean ± SD; *, P < 0.05. Percentages of positive zmpste24 +/+ MEFs were 5.2%, 3.8%, 3.4%, 5.6%, and 4.2%, respectively. (F) HEK293 cells were transfected with ZMP STE24 for 24 h and then infected with the indicated VLPs. Data are representative of two or more experiments per group. Mean ± SD; *, P < 0.05. Percentages of infected cells in the vector transfected control group were 23%, 17%, 18%, 39%, and 26%, respectively. For fusion assays, HEK293 cells were seeded into 24well plates and transfected with pCMV-Tag-4 vector or ZMP STE24-FLAG. To infect zmpste24 +/+ and zmpste24 −/− MEFs, cells were split into six-well plates and cultured in Opti-MEM. VLPs were added, and then plates were centrifuged for 60 min at 450 g, 4°C, followed by 2-4 h incubation at 37°C. To detect β-lactamase activity by flow cytometry, cells were detached with 0.1% trypsin/EDTA. Samples were gated on live cells for 10,000 events and an-alyzed for the emission of uncleaved CCF2 at 520 nm and cleaved CCF2 at 447 nm. Immunoprecipitation 1 × 10 6 cells were lysed in 500 µl TAP lysis buffer (50 mM Tris-HCl [pH 7.5], 10 mM MgCl 2 , 100 mM NaCl, 0.5% Nonidet P40, 10% glycerol, and Complete EDTA-free protease inhibitor cocktail tablets [Roche]) for 30 min at 4°C. Protein samples were heated at 60°C for 10 min. For im- (F) Relative increase in pulmonary RNA levels ± SD for cytokines (IL-6, TNF, and IFNβ) and chemokines (MCP1 and KC) in IAV-infected (day 2) mice (three to five animals per group) from D. Normalized to day 0 levels, the L32 housekeeping gene was used to establish comparable levels of RNA in all groups. *, P < 0.05. (G) IFI TM3 and ZMP STE24 mRNA expression in IAV-infected (day 2) lungs from D. Normalized to day 0 levels, the L32 housekeeping gene was used to normalize RNA levels. Mean ± SD; *, P < 0.05. NA indicates not applicable. munoprecipitation, 2% of cell lysates (10 6 cells) were saved for input control, and the remainder was incubated with 10 µl EZview Red Anti-HA Affinity Gel (Sigma-Aldrich). After mixing end-over-end at 4°C overnight, the beads were washed three times (1 min per wash) with 500 µl lysis buffer. Anti-HA Affinity Gel was eluted with 50 µl of 1 mg/ml HA peptide (Sigma-Aldrich). AP-MS procedures and analyses are detailed elsewhere (Fu et al., 2015) . Methods for AP-MS were described previously (Fu et al., 2015) . SAI NT scores were calculated following established procedures (Choi et al., 2011) .
Immunofluorescence assay
Cells were cultured in the Lab-Tek II Chamber Slide with Cover CC2 Glass Slide Sterile (4 wells; Thermo Fisher Scientific). After indicated treatment, cells were fixed and permeabilized using cold methanol for 10 min at −20°C. The slides were then washed with PBS for 10 min and blocked with Odyssey Blocking Buffer (LI-COR Biosciences) for 1 h. Slides were incubated in Odyssey Blocking Buffer with appropriately diluted primary antibodies at 4°C for 16 h. After three washes (5 min per wash) with PBS, cells were incubated with corresponding Alexa Fluor-conjugated secondary antibodies (Thermo Fisher Scientific) for 1 h at room temperature. The slides were washed three times (5 min each time) with PBS and counter stained with 300 nM DAPI for 1 min, followed by PBS washing for 1 min. After air drying, slides were sealed with Gold Seal Cover Glass (Electron Microscopy Sciences) using Fluorogel (Electron Microscopy Sciences). Images were captured and analyzed using a FluoView confocal microscope (Olympus). At least 20 cells were analyzed in each experiment, and representative data from three experiments are presented.
real-time Pcr
Lungs and spleens were collected in 1 ml RNAlater (Ambion) and stored at −80°C. Specimens were homogenized using the TissueLyser II apparatus (QIA GEN). Total RNA was prepared using RNeasy columns (QIA GEN), after which the RNA was treated with RNase-free DNase to remove contaminating DNA. 1 µg RNA was transcribed into cDNA using QuantiTect reverse transcription kit (QIA GEN). For one real-time reaction, a 20 µl SYBR green PCR reaction mix (Roche) including 1/10 of the synthesized cDNA plus an appropriate oligonucleotide primer pair was run on the LightCycler 480 (Roche). The comparative Ct method was used to determine relative mRNA expression of genes as normalized by the housekeeping genes, GAP DH or L32. Primer sequences are listed in Table 1 . statistical analysis Unless noted otherwise, statistical significance was determined by two-tailed Student's t test for two groups. Analyses with a probability value <0.05 were considered statistically significant. online supplemental material Table S1 , included as an Excel file, shows an AP-MS dataset. acknoWledgMents
